Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 406

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 406
---
| Laura Barberio  |     |  53 |     | Director       |

Biographical information for the members of Heritas Argentina’s board of directors is set forth below. Fabian Fay.Upon the Closing of the Business Combination, Mr. Fay is expected to serve as director of the Company. Mr. Fay has served as the Chief Executive Officer of Parent since its inception in 2021. He has held positions such as director of Grupo Oroño, an Argentinean Health Group, since 2022, member of the Endeavor Argentina Regional Board of Directors from 2015 to 2022, president of the Latin American Association of Private Clinical Laboratories since 2010 and director of Medicina Esencial, a regional health management organization since 2003. He also served as the director of ACLIRES LAB from 2007 to 2011 where he was dedicated to phase 1 clinical trials, director of Sanatorio Parque and the Sanatorio de Niños Lab from 1992 until 2004, director of the Center of Molecular Diagnostics in BioSidus from 1995 to 2001 and director and President of CIBIC Laboratories since 1990. Mr. Fay has actively overseen laboratory operations for local, regional and central laboratories for over 20 clinical trials between

206 1994 and 2015. Mr. Fay also has extensive experience in the introduction of diagnostic technology in Argentina and Latin America. In addition, he was an ad -honoremconsultant for a COVID program with the state of Santa Fe from 2020 until 2023 and has been an ad -honoremconsultant for HIV and Hepatitis National Health Programs with the Argentinean Health Ministry since 2005. Mr. Fay was also an Invited Professor for several post -graduatecourses since 2005 and a member of the Expert Committee on Viral Hepatitis for the Argentinean Association of Liver Diseases. Mr. Fay is a biochemist with a degree from the National University of Rosario, with a post -graduatedegree in clinical pharmacology from the National University of Buenos Aires from 2002. Federico Trucco.Federico Trucco, Ph.D., has served as the Company and Heritas Argentina director since their inception, as the chief executive officer of Bioceres Crop Solutions Crop. (NASDAQ: BIOX) since June 2011 and was appointed as a member of Bioceres S.A.’s board of directors in December 2014 and President of